Position in AMGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$120,508,625
+$30,730,111 QoQ
Shares Held
342,500
+24.9% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,579,687,180 across 10 Drug Manufacturers - General names. AMGN ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
956,817 | $880,051,572 | |
| 2 | JNJ |
Johnson & Johnson
|
2,463,008 | $602,057,675 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,687,439 | $323,272,037 | |
| 4 | ABBV |
AbbVie Inc.
|
1,470,271 | $319,769,239 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
916,513 | $127,734,416 | |
| 6 | AMGN |
Amgen Inc
This page
|
342,500 | $120,508,625 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,466,671 | $88,953,596 | |
| 8 | BIIB |
Biogen Inc.
|
333,457 | $61,132,671 |
All Filings in AMGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,508,625 | 342,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $89,778,514 | 274,292 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,076,682 | 237,692 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,732,717 | 188,864 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $70,369,175 | 225,868 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $79,424,045 | 304,727 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $193,861,513 | 601,662 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $180,688,585 | 578,296 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $119,006,969 | 418,567 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $281,275,723 | 976,584 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $194,111,910 | 722,250 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $80,840,368 | 364,113 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $86,004,013 | 355,756 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $98,027,753 | 373,240 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $35,988,460 | 169,238 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,271,762 | 38,038 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $109,734,664 | 441,038 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $115,681,488 | 503,138 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $157,875,804 | 621,167 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $196,606,291 | 833,572 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $125,666,650 | 619,872 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||